The maker of the ADHD drug Vyvanse has been given approval by the U.S. Drug Enforcement Administration to make more of the medication as a shortage of the critical drugs continues. has been given ...

class 3 or 4 drug-drug interactions (DDIs) did not increase the risk for colchicine-related gastrointestinal adverse events or modify the effect of colchicine on death or hospitalization due to ...

In another blow to Canada's reformist drug policy, British Columbia in April dialed back decriminalizing the possession of drugs such as cocaine and heroin -- in a move advocates say would reduce ...

Drug addiction is a treatable, chronic medical disease that involves complex interactions between a person’s environment, brain circuits, genetics, and life experiences. People with drug addictions ...

(Bloomberg) -- Sandoz Group AG plans to launch a semaglutide generic drug in Canada when the patent for the main ingredient of blockbuster diabetic and weight-loss drugs like Ozempic and Wegovy wears ...

Canadians have prided themselves on embracing newcomers but polls show a growing number say Canada is admitting too many immigrants. That stance is filtering down to border and immigration ...

4:33 Immigration lawyer calls Ottawa’s move to limit temporary foreign workers ‘political’ Canada is closing its doors to more visitors and temporary residents by approving fewer visas and ...

1:40 China takes 1st steps to block Canadian canola imports, escalating trade feud China said on Tuesday it plans to start an anti-dumping investigation into canola imports from Canada ...

In 2023, Canada’s homicide rate was 1.94 homicides per 100,000 residents. While this is roughly double that of western European countries it is still about three times lower than its southern ...

Large Share of US Cancer Cases and Deaths May Be Preventable Roughly 40% of cancer cases and 44% of cancer deaths in the United States in 2019 were attributable to potentially modifiable risk ...

Earn up to $1,300 in value† including up to 40,000 Aeroplan points† and no Annual Fee for the first year†. Conditions Apply. Account must be approved by January 6, 2025.